ME/CFS patients generally showed greater variability in the fold changes of several proteins compared with controls, such as MAGED2, SNCA, GP1BA, and CNPY2. This evidence concerns the gene CNPY2 and myalgic encephalomeyelitis/chronic fatigue syndrome.